References
- Sklar AH, Caruana RJ, Lammers JE, et al. Renal infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1987; 10: 81–88.
- Bennett WM. Evaluation and management of renal infection in patients with adult polycystic kidney disease. In: Grantham JJ, Gardner K Jr., eds. Proceedings of the First International Workshop on Polycystic Kidney Disease. Kansas City: Inter-collegiate Press, 1985: 98–105.
- Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 1994; 41: 295–310.
- Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formula-tions of amphotericin B: clinical efficacy and toxicities. ClM Infect Dis 1998; 27: 603–618.
- Slavin MA, Osborne B, Adams R, et al. Efficacy and safety of fluconazole prophylaxis for fungal infections after bone marrow transplantation A prospective, randomized, double-blind study. J Infect Dis 1995; 171: 1545–1552.
- Wingard JR, Merz WG, Rinaldi MG, et al. Increase in Candida krusei infection among patients with bone marrow transplanta-tion and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274–1277.
- Abbas J, Bodey GP, Hanna HA, et al. Candida krusei fungemia: an escalating serious infection in immunocompromised patients. Arch Intern Med 2000; 160: 2659–2664.
- Muther RS, Bennett WM. Cyst fluid antibiotic concentration in polycystic kidney disease: difference between proximal and distal cysts. Kidney Int 1981; 20: 519–522.
- Bennett WM, Elzinga L, Pulliam JP, et al. Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney dis-ease. Am J Kidney Dis 1985; 6: 400–404.
- Alak A., Moy S, Bekersky I. A high-performance liquid chromatographic assay for the determination of amphotericin B serum concentrations after the administration of AmBisome, a liposomal amphotericin B formulation. Ther Drug Monit 1996; 18: 604–609.